Opaleye Management’s Grace Therapeutics GRCE Stock Holding History
Bought
Maintained
Sold
Other funds holding GRCE
Opaleye Management's GRCE Position: Q3 2026 in Review
Opaleye Management opened a new position in Grace Therapeutics (GRCE) in Q3 2026: 2,798,167 shares worth $6.02M. The stake represents 0.68% of the portfolio and ranks #27 among its holdings.
38 funds tracked by Wall St. Rank hold GRCE as of Q3 2026.
- Opaleye Management held 2,798,167 shares of Grace Therapeutics worth $6.02M as of Q3 2026.
- Grace Therapeutics was a new Opaleye Management position in Q3 2026.
- Grace Therapeutics made up 0.68% of Opaleye Management's portfolio in Q3 2026, its #27 holding.
- 38 funds tracked by Wall St. Rank held Grace Therapeutics as of Q3 2026.
Based on Opaleye Management's 13F filing for Q3 2026, filed 16 Nov 2026.